Home > News By Company > RNCOS
RNCOS Releases a New Report - German Pharma Sector Analysis
RNCOS has recently added a new Market Research Report titled, “German Pharma Sector Analysis” to its report gallery. The report provides extensive research of the German pharmaceutical industry.
(EMAILWIRE.COM, May 17, 2010 ) New Delhi, India - RNCOS has recently added a new Market Research Report titled, “German Pharma Sector Analysis” to its report gallery. Germany is one of the largest pharmaceutical markets in the world. Most of the pharma companies in Germany are focused on research, which has led the country to become one of the most advanced pharma markets in the world. The country’s pharmaceutical market is estimated to have generated revenues of more than Euro 23 Billion (US$ 32.2 Billion) in 2009, and a consistent and strong growth is anticipated in the market for the next few years.
Our latest research report “German Pharma Sector Analysis” says that most of the growth in the sector will be driven by new and innovative product launches and increasing exports to the Asian and Eastern European market. At present, exports dominate the overall market and the same trend is expected to continue in future as well.
Moreover, it is anticipated that the market will experience a surge in M&A activities in the R&D segment. Therefore, this particular segment of the industry is anticipated to experience better growth in comparison to the production and manufacturing segment. However, it is expected that most of the major pharma firms will continue to expand their manufacturing capabilities.
The report also covers latest market trends on both company and overall industry level, which give a clear picture about the current industry scenario. Also, it provides a complete overview of the regulatory environment in the country’s pharmaceutical market.
“German Pharma Sector Analysis” provides thoroughly researched information, authentic data and comparable statistics of the German pharmaceutical industry. The report studies industrial developments and competitive landscape to enable clients understands the market structure and its progress in coming years. Overall, the report will prove useful to the clients looking to invest or making joint ventures in Germany’s pharmaceutical market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM191.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Our latest research report “German Pharma Sector Analysis” says that most of the growth in the sector will be driven by new and innovative product launches and increasing exports to the Asian and Eastern European market. At present, exports dominate the overall market and the same trend is expected to continue in future as well.
Moreover, it is anticipated that the market will experience a surge in M&A activities in the R&D segment. Therefore, this particular segment of the industry is anticipated to experience better growth in comparison to the production and manufacturing segment. However, it is expected that most of the major pharma firms will continue to expand their manufacturing capabilities.
The report also covers latest market trends on both company and overall industry level, which give a clear picture about the current industry scenario. Also, it provides a complete overview of the regulatory environment in the country’s pharmaceutical market.
“German Pharma Sector Analysis” provides thoroughly researched information, authentic data and comparable statistics of the German pharmaceutical industry. The report studies industrial developments and competitive landscape to enable clients understands the market structure and its progress in coming years. Overall, the report will prove useful to the clients looking to invest or making joint ventures in Germany’s pharmaceutical market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM191.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




